Dr. Joel H. Datloff, MD
Dermatology (Dermatology Physician)
8614 E Mill Plain Blvd, Suite 400
Vancouver, WA 98664
Who else practices at this address →
Clark County includes primary care (18% of residents) and dental (4% of residents) and mental health (11% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of North Texas Hsc, College of Osteopathic Med (1982)
- Years since graduation
- 44
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 694
Licensed in Washington since 1986, according to the Washington State Department of Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1982Medical school: University of North Texas Hsc, College of Osteopathic Med
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
WA license MD00023811 (first issued 1986; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Dermatology Associates of Southwest Washington, PLLC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 694
- Services billed
- 3,617
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,478 | 244 |
| Established patient office or other outpatient visit, 20-29 minutes | 455 | 339 |
| Destruction of precancer skin growth, 1 growth | 448 | 303 |
| Pathology examination of tissue using a microscope, intermediate complexity | 377 | 256 |
| Established patient office or other outpatient visit, 30-39 minutes | 269 | 202 |
| Destruction of skin growth, 1-14 growths | 250 | 199 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 93 | 21 |
| Injection, dexamethasone sodium phosphate, 1 mg | 72 | 12 |
| Established patient office or other outpatient visit, 10-19 minutes | 71 | 64 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 54 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Triamcinolone Acetonide Other prescribers in Vancouver, WA | 174 |
| Ketoconazole Other prescribers in Vancouver, WA | 163 |
| Clobetasol Propionate Other prescribers in Vancouver, WA | 122 |
| Metronidazole Other prescribers in Vancouver, WA | 76 |
| Fluorouracil Other prescribers in Vancouver, WA | 73 |
| Doxycycline Hyclate Other prescribers in Vancouver, WA | 56 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Vancouver, WA | 54 |
| Hydrocortisone Other prescribers in Vancouver, WA | 46 |
| Betamethasone Diprop Augmented (betamethasone/propylene glyc) | 46 |
| Clindamycin Phosphate Other prescribers in Vancouver, WA | 45 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 55 payments worth $1,208 in total to this clinician.
| Janssen Biotech, Inc. | $359 |
|---|---|
| UCB, Inc. | $301 |
| AbbVie Inc. | $186 |
| Galderma Laboratories, L.P. | $158 |
| Arcutis Biotherapeutics, Inc. | $57.39 |
| Novartis Pharmaceuticals Corporation | $39.89 |
| Leo Pharma Inc. | $39.44 |
| Amgen Inc. | $19.88 |
| Food and Beverage | $1,109 |
|---|---|
| Education | $99.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. May 23, 2025 | Education TREMFYA · Immunology · in-kind | $99.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.